Summit Creek Advisors LLC Has $11.50 Million Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Summit Creek Advisors LLC cut its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 0.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 495,657 shares of the company’s stock after selling 4,635 shares during the period. Summit Creek Advisors LLC’s holdings in Option Care Health were worth $11,499,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of OPCH. UMB Bank n.a. increased its stake in shares of Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after purchasing an additional 346 shares during the last quarter. Signaturefd LLC grew its stake in Option Care Health by 487.9% in the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock valued at $28,000 after buying an additional 1,005 shares during the last quarter. Quarry LP grew its stake in Option Care Health by 327.7% in the 3rd quarter. Quarry LP now owns 3,430 shares of the company’s stock valued at $107,000 after buying an additional 2,628 shares during the last quarter. Blue Trust Inc. grew its stake in Option Care Health by 16.9% in the 4th quarter. Blue Trust Inc. now owns 4,703 shares of the company’s stock valued at $109,000 after buying an additional 681 shares during the last quarter. Finally, Venturi Wealth Management LLC grew its stake in Option Care Health by 2,621.3% in the 4th quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company’s stock valued at $110,000 after buying an additional 4,561 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Option Care Health

In other news, insider Michael Bavaro sold 30,996 shares of the company’s stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares of the company’s stock, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.64% of the stock is currently owned by insiders.

Option Care Health Stock Performance

NASDAQ OPCH opened at $34.58 on Monday. The firm has a 50-day moving average price of $31.84 and a two-hundred day moving average price of $28.29. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $34.85. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The company has a market capitalization of $5.72 billion, a P/E ratio of 29.06, a P/E/G ratio of 2.30 and a beta of 1.33.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on OPCH. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and upped their price target for the company from $26.00 to $35.00 in a research note on Thursday, January 23rd. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their price target for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Barrington Research upped their price target on shares of Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a research note on Thursday, February 27th. JPMorgan Chase & Co. upped their price target on shares of Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research note on Thursday, March 6th. Finally, UBS Group initiated coverage on shares of Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $33.00.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.